Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
Title | Innate Biotherapeutics - Biotech Company - mAbXcite |
Description | About Innate Biotherapeutics is a biotech company developing immunotherapies that convert the immunosuppressive tumor microenvironment into an immunostimulatory one, by activating both innate and adaptive immune cells, and thus selectively treat a wide |
Keywords | N/A |
WebSite | immunexcite.com |
Host IP | 98.137.244.30 |
Location | United States |
Site | Rank |
US$1,274
Last updated: 2022-10-07 20:46:58
immunexcite.com has Semrush global rank of 0. immunexcite.com has an estimated worth of US$ 1,274, based on its estimated Ads revenue. immunexcite.com receives approximately 147 unique visitors each day. Its web server is located in United States, with IP address 98.137.244.30. According to SiteAdvisor, immunexcite.com is safe to visit. |
Purchase/Sale Value | US$1,274 |
Daily Ads Revenue | US$1 |
Monthly Ads Revenue | US$35 |
Yearly Ads Revenue | US$423 |
Daily Unique Visitors | 9 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
immunexcite.com. | A | 1199 | IP: 98.137.244.30 |
immunexcite.com. | NS | 86400 | NS Record: yns1.yahoo.com. |
immunexcite.com. | NS | 86400 | NS Record: yns2.yahoo.com. |
immunexcite.com. | MX | 600 | MX Record: 0 immunexcite-com.mail.protection.outlook.com. |
immunexcite.com. | TXT | 600 | TXT Record: google-site-verification=VQ6mL7AhNBSPFy5Eg-xBsacttvlD42kEgDj8YRccdQU |
immunexcite.com. | TXT | 600 | TXT Record: dca567d2998984e25bbb54920d486a8907491ed6 |
info@innatebio.com About Our Technology Partnering Contact Us Select Page About Us Innate Bio’s platform is based on an engineered fungal carbohydrate that stimulates the innate immune system—our body’s first response against fungal infections. These carbohydrates are covalently linked to tumor-targeting monoclonal antibodies, which attract pre-existing antibodies, activate the complement system, and ultimately recruit innate immune cells to kill the tumor cells. This innate immune response primes the natural adaptive immune response to convert the immunosuppressive tumor microenvironment into an immunostimulatory one and to eliminate tumor growth and metastasis. Innate Bio’s pre-clinical pipeline has the following advantages: A strong IP portfolio, including compositions and use claims Lead programs that have gone through optimization and extensive pre-clinical testing, including pilot toxicity in non-human primates Several compelling market opportunities in the cancer immunotherapy |
HTTP/1.1 200 OK Date: Sat, 30 Oct 2021 16:26:24 GMT P3P: policyref="https://policies.yahoo.com/w3c/p3p.xml", CP="CAO DSP COR CUR ADM DEV TAI PSA PSD IVAi IVDi CONi TELo OTPi OUR DELi SAMi OTRi UNRi PUBi IND PHY ONL UNI PUR FIN COM NAV INT DEM CNT STA POL HEA PRE LOC GOV" Expires: Mon, 26 Jul 1997 05:00:00 GMT Cache-Control: private, post-check=0, precheck=0 Pragma: no-cache Vary: Accept-Encoding Content-Type: text/html; charset=UTF-8 Age: 0 Connection: keep-alive Server: ATS |
Domain Name: IMMUNEXCITE.COM Registry Domain ID: 777594877_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.tucows.com Registrar URL: http://www.tucows.com Updated Date: 2020-12-28T06:27:25Z Creation Date: 2007-01-26T17:58:07Z Registry Expiry Date: 2022-01-26T17:58:07Z Registrar: Tucows Domains Inc. Registrar IANA ID: 69 Domain Status: ok https://icann.org/epp#ok Name Server: YNS1.YAHOO.COM Name Server: YNS2.YAHOO.COM DNSSEC: unsigned >>> Last update of whois database: 2021-09-18T02:45:52Z <<< |